Data Bridge Market Research analyses that the Virology Testing Market which was USD 4,108.27 million in 2021, would rocket up to USD 7717.51 million by 2029, and is expected to undergo a CAGR of 8.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download the Free PDF Sample Report (Including FULL TOC, Graphs, and Tables) of this report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Recent Development

In May 2021, In collaboration with Ubio Biotechnology Systems Pvt. Ltd., Cipla Limited introduced “ViraGen” as a polymerase chain reaction (COVID-19 RT-PCR) test for COVID-19 in India.

In May 2022, QuantuMDx Group Limited announced the release of Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a novel respiratory panel test. Rapid point-of-care testing is offered to customers through the Q-POC platform and its multiplex capabilities in clinical and non-clinical contexts.

In January 2022, A brand-new, extremely sensitive SARS-CoV-2 Rapid Antigen Test -AQ+ Covid-19 Ag Rapid Test for usage by professionals was introduced by InTec. The AQ+ Covid-19 Ag Rapid Test is designed to be used by laypeople or medical professionals to quickly and easily detect Covid-19.

Virology Testing Market Analysis and Size

The virology testing market is expected to grow at a significant growth rate. The new advanced molecular-based virology testing methods, such as immunoassay, mass spectrometry-based detection methods, nucleic acid-based amplification testing methods, and next-generation genome sequencing methods, are precise, quick, and provides the result for various viral infections.

Testing for viruses includes diagnostic techniques that aid in the early detection of illnesses such as hepatitis, influenza, HIV, sexually transmitted diseases, RCV, and other viruses-related diseases. Virology testing looks for the presence of viral antigens, nucleic acids, and antibodies in the provided sample. There have been identified more than 100 viral illnesses.

Some of the major players operating in the virology testing market are:

Hoffmann-La Roche Ltd (Switzerland)

Agilent Technologies, Inc. (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

QIAGEN (Germany)

Lonza (Switzerland)

Sigma-Aldrich Co. (U.S.)

Wuxi AppTec (China)

Merck & Co. Inc. (U.S.)

Eurofins Scientific (Luxembourg)

General Electric (U.S.)

Danaher (U.S.)

Sartorius AG (Germany)

Bio-Rad Laboratories, Inc. (U.S.)

BD (U.S.)

Biospherix, Ltd (U.S.)

Novogene Co Ltd. (China)

View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-virology-te...

Key Pointers Covered in This Market Research Report:

Market Size

Market New Sales Volumes

Market Replacement Sales Volumes

Introduced Base

Market By Brands

Market Procedure Volumes

Market Product Price Analysis

Market Healthcare Outcomes

Market Cost of Care Analysis

Administrative Framework and Changes

Costs and Reimbursement Analysis

Pieces of the pie in Different Regions

Ongoing Developments for Market Competitors

Market Upcoming Applications

Market Innovators Study

Virology Testing Market Dynamics

Drivers

Rising number of patients with STDs

In the forecast period of 2022–2029, factors such as the rising number of patients with STDs, STD-related illnesses, and other viruses, as well as the availability of immune suppressive drugs and the rising number of technological advancements in the healthcare industry, are likely to boost the growth of the virology testing market. However, the development of molecular diagnostic technologies will create a number of new chances for the virology testing market to expand during the forecast period.

Rising incidence of viral infections

The main driving factors will be the rising incidence of viral infections, the appearance of novel pathogens, and an increase in the number of product approvals. For instance, the World Health Organization (WHO) estimates that in 2021, infectious diseases affected 60% of the world’s population. The demand for virology testing has increased due to the rising prevalence of viral illnesses such as human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other sexually transmitted diseases.

Opportunities

Increased healthcare spending

The rapid adoption of cutting-edge diagnostic and testing techniques, increased healthcare spending, the existence of supportive government policies, and the presence of cutting-edge clinical laboratories and manufacturing businesses have all contributed to the region’s market’s robust growth over the years. An important reason for the market’s expansin is the rise in R&D efforts from public and commercial organizations in the United States.

Restraints/Challenges

Stringent regulations regarding product development and approvals

On the other hand, the stringent approval processes along with side effects of drugs and other treatment options will obstruct the market’s growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the virology testing market.

This virology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the virology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Virology Testing Market

The COVID-19 pandemic has also significantly impacted the development of the segment. Nearly all diagnostic tests employ RT-PCR to screen the population who have COVID-19 symptoms because the authorities have not recommended the specific viral culture tests. To find novel compounds or leads for the treatment of COVID-19, the majority of pharmaceutical and biotechnological businesses are concentrating on research and development operations.

Complete Report is available (Including the full TOC, Tables and Figures, Graphs as well as Chart) @ https://www.databridgemarketresearch.com/toc/?dbmr=global-virology-...

Global Virology Testing Market Scope

The virology testing market is segmented on the basis of procedure, diagnosis test, method, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure

Cell Culture Method

Specific Antibodies Detection

Antigen Detection

Virus Nucleic Acid Detection

Gene Sequencing

Hemagglutination Assays

Diagnosis Test

Hepatitis B

Hepatitis C

HIV

Human Papillomavirus (HPV)

Other Tests

Method

Immunoprophylaxis

Active Prophylaxis (Vaccines)

Passive Prophylaxis

Antiviral Chemotherapy

Interferon’s (Cytokines)

Application

Skin and Soft Tissue Infections

Respiratory Tract Infections

GI Tract Infections

Urinary Tract Infection

Eye Infections

Sexually Transmitted Diseases

Perinatal Infections

End User

Hospitals

Clinics

Laboratories

Diagnostic Centers

Blood Banks

Pharmacies